v3.26.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Revenue $ 28 $ 0
Operating costs and expenses:    
Research and development 6,033 6,718
Selling, general and administrative 7,479 8,534
Total operating costs and expenses 13,512 15,252
Loss from operations (13,484) (15,252)
Other (expense) income, net:    
Interest income and other income, net 436 679
Gain on sale of future payments 0 1,246
(Loss) gain on change in fair value of warrant liability (1,315) 717
Non-cash interest expense on liability related to the sale of future payments 0 (394)
Total other income, net (879) 2,248
Net loss from continuing operations (14,363) (13,004)
Net income from discontinued operations – See Note 3 73 0
Net loss $ (14,290) $ (13,004)
Net loss per share attributable to stockholders:    
Basic and diluted, continuing operations (in dollars per share) $ (0.34) $ (0.5)
Basic and diluted, discontinued operations (in dollars per share) 0 0
Basic and diluted loss per share (in dollars per share) $ (0.34) $ (0.5)
Shares used in computing net loss per share of common stock, basic and diluted – See Note 10 (in shares) 42,410,711 25,845,639